drugset / Trial / NCT00377247
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
NaSingle-groupOpen-labelTreatment
Summary
The primary goal of this study is to determine if the vaccine can be safely given to subjects, and to see what side effects occur (both good and bad) when they are given this experimental tumor vaccine. During this study, investigators intend to watch for tumor response while examining the effects of this vaccine on the body's immune system after it is given.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-04
- Completion
- 2009-04
Outcome
Outcome not reported
Stopped (Enrollment): “study closed to accrual due to slow accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous monocyte-derived dendritic cells (DC) transfected with DNA | Cell therapy | 1e+07 cells | Other |